These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 13678554)

  • 1. Hallucinogens: an update.
    Halpern JH
    Curr Psychiatry Rep; 2003 Oct; 5(5):347-54. PubMed ID: 13678554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hallucinogen persisting perception disorder: what do we know after 50 years?
    Halpern JH; Pope HG
    Drug Alcohol Depend; 2003 Mar; 69(2):109-19. PubMed ID: 12609692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synesthesias in the context of hallucinogen-induced persistent perception disorder following the use of lsd].
    Neven A; Blom JD
    Tijdschr Psychiatr; 2014; 56(11):748-52. PubMed ID: 25401683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who takes the trip? Personality and hallucinogen use among college students and adolescents.
    Parnes JE; Kentopp SD; Conner BT; Rebecca RA
    Drug Alcohol Depend; 2020 Dec; 217():108263. PubMed ID: 32932162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia and hallucinogen persisting perception disorder: A clinical investigation.
    Lev-Ran S; Feingold D; Rudinski D; Katz S; Arturo LG
    Am J Addict; 2015 Apr; 24(3):197-199. PubMed ID: 25808913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinogen persisting perception disorder after psilocybin consumption: a case study.
    Espiard ML; Lecardeur L; Abadie P; Halbecq I; Dollfus S
    Eur Psychiatry; 2005 Aug; 20(5-6):458-60. PubMed ID: 15963699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hallucinogen Persisting Perception Disorder and Risk of Suicide.
    Brodrick J; Mitchell BG
    J Pharm Pract; 2016 Aug; 29(4):431-4. PubMed ID: 25631475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A regulatory perspective on the evaluation of hallucinogen drugs for human use.
    Calderon SN; Hunt J; Klein M
    Neuropharmacology; 2018 Nov; 142():135-142. PubMed ID: 29180224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonidine treatment for hallucinogen persisting perception disorder.
    Lerner AG; Finkel B; Oyffe I; Merenzon I; Sigal M
    Am J Psychiatry; 1998 Oct; 155(10):1460. PubMed ID: 9766785
    [No Abstract]   [Full Text] [Related]  

  • 10. Salvia divinorum: An overview of the usage, misuse, and addiction processes.
    Mahendran R; Lim HA; Tan JY; Chua SM; Winslow M
    Asia Pac Psychiatry; 2016 Mar; 8(1):23-31. PubMed ID: 26617400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The trip of a lifetime: hallucinogen persisting perceptual disorder.
    Anderson L; Lake H; Walterfang M
    Australas Psychiatry; 2018 Feb; 26(1):11-12. PubMed ID: 28836813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association of Salvia divinorum and Psychotic Disorders: A Review of the Literature and Case Series.
    El-Khoury J; Sahakian N
    J Psychoactive Drugs; 2015; 47(4):286-92. PubMed ID: 26317561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD.
    Halpern JH; Lerner AG; Passie T
    Curr Top Behav Neurosci; 2018; 36():333-360. PubMed ID: 27822679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment.
    Doyle MA; Ling S; Lui LMW; Fragnelli P; Teopiz KM; Ho R; Di Vincenzo JD; Rosenblat JD; Gillissie ES; Nogo D; Ceban F; Jawad MY; McIntyre RS
    Expert Opin Drug Saf; 2022 Jun; 21(6):733-743. PubMed ID: 35426769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of adolescent Salvia divinorum use in Canada.
    Currie CL
    Drug Alcohol Depend; 2013 Feb; 128(1-2):166-70. PubMed ID: 22967837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abuse and Effects of Salvia divinorum in a Sample of Patients Hospitalized for Substance Dependence.
    Karam A; Said A; Assaad C; Hallit S; Haddad G; Hachem D; Kazour F
    Community Ment Health J; 2019 May; 55(4):702-708. PubMed ID: 30374761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence.
    Knuijver T; Belgers M; Markus W; Verkes RJ; van Oosteren T; Schellekens A
    J Clin Psychopharmacol; 2018 Dec; 38(6):646-648. PubMed ID: 30300292
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthetic Cannabis Substances (SPS) Use and Hallucinogen Persisting Perception Disorder (HPPD): Two Case Reports.
    G Lerner A; Goodman C; Bor O; Lev-Ran S
    Isr J Psychiatry Relat Sci; 2014; 51(4):277-80. PubMed ID: 25841224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case series: Salvia divinorum as a potential addictive hallucinogen.
    El-Khoury J; Baroud E
    Am J Addict; 2018 Apr; 27(3):163-165. PubMed ID: 29596726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hallucinogen-induced psychological disorders].
    Hermle L; Kovar KA; Hewer W; Ruchsow M
    Fortschr Neurol Psychiatr; 2008 Jun; 76(6):334-42. PubMed ID: 18512184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.